Qube Research & Technologies LTD Forma Therapeutics Holdings, Inc. Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
BUY
$7.12 - $20.24 $1.18 Million - $3.37 Million
166,372 Added 472.45%
201,587 $4.02 Million
Q2 2022

Aug 15, 2022
SELL
$5.1 - $10.0 $278,582 - $546,240
-54,624 Reduced 60.8%
35,215 $243,000
Q1 2022

May 09, 2022
BUY
$8.34 - $14.69 $640,878 - $1.13 Million
76,844 Added 591.34%
89,839 $836,000
Q4 2021

Feb 01, 2022
BUY
$13.6 - $24.89 $176,732 - $323,445
12,995 New
12,995 $185,000

Others Institutions Holding FMTX

# of Institutions
2
Shares Held
26.5K
Call Options Held
0
Put Options Held
0
View Full List

About Forma Therapeutics Holdings, Inc.

FMTX Quotes by TradingView
  • Ticker FMTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,860,400
  • Market Cap $958M
  • Description
  • Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatment of sickle cell disease and other hemoglobin...
More about FMTX
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email